Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Speciallægeselskabet Ursula Bentin-Ley ApS
APS
Active
CVR 43875523
Bakkefaldet 14, 2840
Holte
Medical specialists activities
· NACE 8622
Est. 2023
1 employees
Watchlist
Share
Denmark
/
Companies
/
Medical specialists activities
/
Speciallægeselskabet Ursula Bentin-Ley ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
1M
2M
3M
3M
3M
2023
2M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
2.727
2.101
Staff expenses
-1.982
-816
EBITDA
745
1.285
Depreciation & amort.
-93
-61
EBIT
652
1.224
Net financials
334
500
Profit before tax
985
1.724
Tax
255
400
Net profit
730
1.324
Balance sheet
DKK thousands
Item
2023
2024
Total assets
2.085
2.865
Equity
1.481
2.805
Long-term debt
0
0
Short-term debt
555
38
Total debt
555
38
Financial ratios
5-year trend
EBITDA margin
61.2%
This company
15.8%
Market median
+287% vs market
2023
2024
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
2023
2024
Return on equity
47.2%
This company
18.4%
Market median
+157% vs market
2023
2024
Net profit margin
63.0%
This company
8.1%
Market median
+678% vs market
2023
2024
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
2023
2024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
More on Speciallægeselskabet Ursula Bentin-Ley ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
